Search

everythinglearnresearchcommunity

for

Search:↓

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Calcipotriol is the safest and most effective for hair regrowth in localized alopecia areata.

The VSCAPSI is a helpful method for evaluating the severity of scalp psoriasis.

Baricitinib-loaded EVs help hair regrowth in alopecia areata by reducing inflammation and promoting hair follicle regeneration.

Combining calcipotriol with mometasone is more effective for treating alopecia areata than using mometasone alone.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Baricitinib may effectively treat oral lichen planus.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

HAC and BAC improve skin targeting and reduce diffusion without causing irritation.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Avicennia Marina extract and avicequinone C can reduce hair loss hormone production and increase hair growth factors, suggesting they could be used to treat androgenic alopecia.

A new test more accurately detects citrulline in hair follicles and pilomatrixomas.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Clofazimine effectively treated ashy dermatosis in a patient.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Effective immunomodulatory treatments and a personalized approach are crucial for managing severe folliculitis decalvans.

Hydroxychloroquine might help prevent COVID-19, but more research is needed.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

A new treatment using valproic acid helps regrow hair safely.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

The serum effectively reduces hair loss and improves hair growth without side effects.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Intermittent isotretinoin can cause various skin, hair, and nail changes.

An adult had a rare scalp infection in the forehead area, treated successfully with itraconazole.

New acne treatments include combination creams, advanced retinoids, and light therapies, focusing on safety and patient adherence.